News

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...
Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...
Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in ...
Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data ...
However, early diagnosis and treatment are the key for better management of the rheumatoid arthritis. The global rheumatoid arthritis drugs market is segmented into drug class, route of administration ...
The Rheumatoid Arthritis Drugs/Therapeutics market revenue was $$ Million USD in 2022, grew to $$ Million USD in 2024, and will reach $$ Million USD in 2032, with a CAGR of $% during 2024-2032.
It is currently being evaluated for the treatment of systemic lupus erythematosus ... "Cullinan Therapeutics receives EMA approval for rheumatoid arthritis drug trial" was originally created ...
Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.
Visible signs of psoriatic arthritis appear months and even years before a person develops the full-blown inflammatory joint ...